{"transactions":[{"id":3137695,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":141335,"kind":"person","name":"Kleijwegt Martijn","position":1,"cik":"0001726016","reported_name":"Kleijwegt Martijn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T20:10:15.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 20, 2021 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":3.39,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001298","document":"form4-05222020_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001298/form4-05222020_040501.xml","form_type":"4"}},{"id":3507783,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":141335,"kind":"person","name":"Kleijwegt Martijn","position":1,"cik":"0001726016","reported_name":"Kleijwegt Martijn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-30T18:06:06.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on May 29, 2020 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.02,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000630","document":"form4-05302019_110553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000630/form4-05302019_110553.xml","form_type":"4"}},{"id":3889176,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":141335,"kind":"person","name":"Kleijwegt Martijn","position":1,"cik":"0001726016","reported_name":"Kleijwegt Martijn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T22:12:11.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":23.27,"expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-038656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038656/doc4.xml","form_type":"4"}},{"id":3952305,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":141335,"kind":"person","name":"Kleijwegt Martijn","position":1,"cik":"0001726016","reported_name":"Kleijwegt Martijn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-01T20:32:58.000Z","date":"2018-04-30","kind":"purchase","acquired":true,"shares":300000,"price":9.75,"value":2925000.0,"ownership":{"direct":false,"nature":"By LSP investment fund"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the purchase of shares in the follow-on offering of Common Stock of Eloxx Pharmaceuticals, Inc. that closed on April 30, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares of the Issuer held by LSP V Cooperatieve U.A. (\"LSP V\"). LSP V Management B.V. (\"LSP V Management\") is the director and manager of LSP V. Mr. Kleijwegt is a Managing Director of LSP V Management. By virtue of this relationship, Mr. Kleijwegt may be deemed to share voting and dispositive power with respect to the shares held by LSP V. Mr. Kleijwegt disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise."}],"balance_after":2953673,"source":{"system":"sec-edgar","filing":"0001209191-18-027108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118027108/doc4.xml","form_type":"4"}}]}